University of Pennsylvania
Philadelphia, Pennsylvania, United States
Purpose
to develop and test novel simian-human immunodeficiency viruses (in nonhuman primates) that elicit broadly neutralizing antibodies and could serve as a guide for iterative HIV/AIDS vaccine development
Division
Global Health
Date
February 2016
Region Served
GLOBAL
Committed amount
$4,143,430
Grant topic
HIV
Duration (months)
37
Grantee location
Philadelphia, Pennsylvania, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.